project id: TCGA-KIRC; case submitter id: TCGA-B8-A54H; analyte type: DNA; source center: 23; state: released; a260 a280 ratio: 1.87; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.68; rna integrity number: 8.9; age at index: 69; days to birth: -25243; ethnicity: not reported; gender: female; race: black or african american; vital status: Alive; year of birth: 1943; age at diagnosis: 25243; ajcc clinical m: M0; ajcc pathologic m: MX; ajcc pathologic n: N0; ajcc pathologic stage: Stage II; ajcc pathologic t: T2a; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 256.0; icd 10 code: C64.9; last known disease status: not reported; morphology: 8312/3; primary diagnosis: Renal cell carcinoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Kidney, NOS; synchronous malignancy: Yes; tissue or organ of origin: Kidney, NOS; tumor grade: Not Reported; year of diagnosis: 2012; treatment or therapy: no; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 160; days to sample procurement: 0; initial weight: 330.0; portion submitter id: TCGA-B8-A54H-01A-11; percent lymphocyte infiltration: 0.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 20.0; percent tumor cells: 80.0; percent tumor nuclei: 95.0;